NFKB1 and bladder transitional cell carcinoma: In bladder urothelial carcinoma, RIPK4 was shown to exhibit a high level and its silence inhibited the tumor growth and migration of bladder urothelial carcinoma cells via modulating NF-κB pathway [13].